Latest Funding News

Aspermont Limited has announced a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a discounted price, aiming to raise up to $1.25 million. The offer opens on September 1 and closes mid-month, with trading expected to start by September 19.

Warriedar Resources reports encouraging assay results from 20 drillholes at its Golden Range Project, confirming extensions of gold mineralisation beyond current estimates at the M1 deposit and validating historical data at Valencia.

PPK Group reported a statutory loss in FY25 driven by a significant non-cash impairment of its lithium-sulfur battery investment, while its ballistics division achieved record revenue and battery sales gained momentum from government programs.

TrivarX Limited reported a reduced net loss of $943K for FY25 alongside a $3.68 million equity raise, yet flagged material uncertainty over its ability to continue as a going concern.

Control Bionics Limited reported a 14.8% revenue increase to $6.14 million for FY2025 but also a 3.3% rise in net loss to $6.11 million, while pursuing a $2 million rights issue and expanding its investment portfolio.

WhiteHawk Limited reports an 8.6% revenue increase and a 26% reduction in net loss for H1 2025, alongside new US government contracts and a $1.56 million capital raise.

Noxopharm Limited reported a 36.5% increase in its annual loss to $4.88 million as it progressed preparations for its SOF-SKN™ clinical trial and secured $2.6 million through convertible notes. The biotech continues to invest heavily in its inflammation and oncology drug pipeline while managing liquidity and strategic partnerships.

Rent.com.au Limited reported a $3.69 million net loss for FY25 amid modest revenue growth, while securing significant funding to scale its RentBond® product and reshaping its leadership team.

Wellard Ltd posts a net profit turnaround in FY2025 despite fleet downsizing, sells its last vessel, and plans to delist from the ASX while returning substantial capital to shareholders.

Cettire Limited reported FY25 results showing stable sales revenue and a breakeven adjusted EBITDA despite a challenging luxury goods market. The company’s strategic focus on profitability, supply chain expansion, and emerging markets diversification underpins its resilience.

Cettire Limited reported stable revenue for FY25 despite a challenging luxury market, but profitability sharply declined due to increased promotional activity and softer demand.

MOVE Logistics Group Limited reported a solid FY25 performance with a 61% improvement in normalised earnings despite a challenging economy, setting the stage for a return to profitability in FY26.